title: An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser.
authors.forename: Paul
authors.initials: P
authors.lastname: England
mesh_terms: D001709:Biotechnology / Q000379:methods* / Q000639:trends; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D005820:Genetic Testing / Q000379:methods / Q000639:trends; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
chemical_list: D047428:Protein Kinase Inhibitors; D011494:Protein Kinases